Mark Gustavson

Senior Director, Computational Pathology AstraZeneca

Seminars

Wednesday 7th October 2026
Panel Discussion: Advancing Regulatory Frameworks & Standards for Compliant Digital Pathology Co-Development
3:10 pm

Presentation Details to be Announced

Right click on the image to save it to your computer.

Wednesday 7th October 2026
Beyond TROP2 NMR: AI & Computational Pathology for IHC-Based Diagnostics
12:50 pm
  • Describing how QCS delivers human interpretable features beyond Normalized Membrane Ratio (NMR) for biomarker Dx development
  • Discussing the future of computational pathology-based IHC diagnostics including the use of controls
  • Examining the future of AI in the development of multimodal-based diagnostics
Mark_Gustavson[1]